These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27686239)

  • 1. Interpretation of Workplace Tests for Cannabinoids.
    Kulig K
    J Med Toxicol; 2017 Mar; 13(1):106-110. PubMed ID: 27686239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
    Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
    Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Workplace drug testing in Italy: findings about second-stage testing.
    Vignali C; Stramesi C; Morini L; San Bartolomeo P; Groppi A
    Drug Test Anal; 2015 Mar; 7(3):173-7. PubMed ID: 24652693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens.
    Wohlfarth A; Scheidweiler KB; Castaneto M; Gandhi AS; Desrosiers NA; Klette KL; Martin TM; Huestis MA
    Clin Chem Lab Med; 2015 Feb; 53(3):423-34. PubMed ID: 25263309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of tools, methods and results of toxicological screening for detection of drug abuse in Italian professional drivers].
    Rosso GL
    Med Lav; 2013; 104(1):30-43. PubMed ID: 23520885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Workplace drug testing in Italy - critical considerations.
    Vignali C; Stramesi C; Morini L; Pozzi F; Collo G; Groppi A
    Drug Test Anal; 2013 Apr; 5(4):208-12. PubMed ID: 23355251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary excretion of cannabis metabolites].
    Kielland KB
    Tidsskr Nor Laegeforen; 1992 May; 112(12):1585-6. PubMed ID: 1615510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current knowledge on cannabinoids in oral fluid.
    Lee D; Huestis MA
    Drug Test Anal; 2014; 6(1-2):88-111. PubMed ID: 23983217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal indication of cannabis use by means of THC glucuronide determination.
    Mareck U; Haenelt N; Geyer H; Guddat S; Kamber M; Brenneisen R; Thevis M; Schänzer W
    Drug Test Anal; 2009 Nov; 1(11-12):505-10. PubMed ID: 20355165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Urine and Oral Fluid for Workplace Drug Testing.
    Casolin A
    J Anal Toxicol; 2016 Sep; 40(7):479-85. PubMed ID: 27344042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Finding cannabinoids in hair does not prove cannabis consumption.
    Moosmann B; Roth N; Auwärter V
    Sci Rep; 2015 Oct; 5():14906. PubMed ID: 26443501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False-positive cannabis results in Italian workplace drug testing.
    Fucci N; De Giovanni N
    Drug Test Anal; 2012 Feb; 4(2):71-3. PubMed ID: 22362572
    [No Abstract]   [Full Text] [Related]  

  • 16. Differentiating new marijuana use from residual drug excretion in occasional marijuana users.
    Huestis MA; Cone EJ
    J Anal Toxicol; 1998 Oct; 22(6):445-54. PubMed ID: 9788519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical dependency and drug testing in the workplace.
    Osterloh JD; Becker CE
    West J Med; 1990 May; 152(5):506-13. PubMed ID: 2190418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmortem Fluid and Tissue Concentrations of THC, 11-OH-THC and THC-COOH.
    Saenz SR; Lewis RJ; Angier MK; Wagner JR
    J Anal Toxicol; 2017 Jul; 41(6):508-516. PubMed ID: 28830124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug and chemical metabolites in clinical toxicology investigations: the importance of ethylene glycol, methanol and cannabinoid metabolite analyses.
    Fraser AD; Coffin L; Worth D
    Clin Biochem; 2002 Oct; 35(7):501-11. PubMed ID: 12493577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marijuana metabolism in the context of urine testing for cannabinoid metabolite.
    Morgan JP
    J Psychoactive Drugs; 1988; 20(1):107-15. PubMed ID: 2839654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.